Oct. 25, 2012
Nine years ago this week, pharmacist Sarah Sellers cited public health concerns with large compounding pharmacies in testimony before a U.S. Senate committee.
At the time, Sellers sat on the U.S. Food and Drug Administration's Advisory Committee on Pharmacy Compounding.
In her testimony, she said compounding pharmacies comprised "a flourishing, unregulated drug industry within our own borders." Sellers also said that, at that time, compounded drugs had been associated with injuries and deaths across the country, including an outbreak of fungal meningitis.
Nearly a decade later, tainted steroids mixed by a Massachusetts compounding pharmacy are be-lieved to have caused another men-ingitis outbreak that has caused multiple deaths, including several in Michigan.
Read entire story here
No comments:
Post a Comment